RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors | Zendy

Fei Su | Zendy; Amaya Virós | Zendy; Carla Milagre | Zendy; Kerstin Trunzer | Zendy; Gideon Bollag | Zendy; Olivia Spleiss | Zendy; Jorge S. ReisFilho | Zendy; Xiangju Kong | Zendy; Richard C. Koya | Zendy; Keith T. Flaherty | Zendy; Paul B. Chapman | Zendy; Min Jung Kim | Zendy; Robert Hayward | Zendy; Matthew J. Martin | Zendy; Hong Yang | Zendy; Qiongqing Wang | Zendy; Holly Hilton | Zendy; Julie S. Hang | Zendy; Johannes Noé | Zendy; Maryou Lambros | Zendy; Felipe C. Geyer | Zendy; Nathalie Dhomen | Zendy; Ion NiculescuDuvaz | Zendy; Alfonso Zambon | Zendy; Dan NiculescuDuvaz | Zendy; Natasha Preece | Zendy; Lídia Robert | Zendy; Nicholas Otte | Zendy; Stephen Mok | Zendy; Damien Kee | Zendy; Yan Ma | Zendy; Chao Zhang | Zendy; Gaston Habets | Zendy; Elizabeth A. Burton | Zendy; Bernice H. Wong | Zendy; Hoa Nguyen | Zendy; Mark Kockx | Zendy; Luc Andries | Zendy; Brian Lestini | Zendy; K. B. Nolop | Zendy; Richard J. Lee | Zendy; Andrew K. Joe | Zendy; James L. Troy | Zendy; René González | Zendy; Thomas E. Hutson | Zendy; Igor Puzanov | Zendy; Bartosz Chmielowski | Zendy; Caroline J. Springer | Zendy; Grant A. McArthur | Zendy; Jeffrey A. Sosman | Zendy; Roger S. Lo | Zendy; Antoni Ribas | Zendy; Richard Marais | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Author(s) -

Fei Su,

Amaya Virós,

Carla Milagre,

Kerstin Trunzer,

Gideon Bollag,

Olivia Spleiss,

Jorge S. ReisFilho,

Xiangju Kong,

Richard C. Koya,

Keith T. Flaherty,

Paul B. Chapman,

Min Jung Kim,

Robert Hayward,

Matthew J. Martin,

Hong Yang,

Qiongqing Wang,

Holly Hilton,

Julie S. Hang,

Johannes Noé,

Maryou Lambros,

Felipe C. Geyer,

Nathalie Dhomen,

Ion NiculescuDuvaz,

Alfonso Zambon,

Dan NiculescuDuvaz,

Natasha Preece,

Lídia Robert,

Nicholas Otte,

Stephen Mok,

Damien Kee,

Yan Ma,

Chao Zhang,

Gaston Habets,

Elizabeth A. Burton,

Bernice H. Wong,

Hoa Nguyen,

Mark Kockx,

Luc Andries,

Brian Lestini,

K. B. Nolop,

Richard J. Lee,

Andrew K. Joe,

James L. Troy,

René González,

Thomas E. Hutson,

Igor Puzanov,

Bartosz Chmielowski,

Caroline J. Springer,

Grant A. McArthur,

Jeffrey A. Sosman,

Roger S. Lo,

Antoni Ribas,

Richard Marais

Publication year - 2012

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1105358

Subject(s) - hras , vemurafenib , neuroblastoma ras viral oncogene homolog , kras , cancer research , mapk/erk pathway , carcinogenesis , v600e , cell growth , mutation , biology , medicine , kinase , melanoma , cancer , gene , genetics , metastatic melanoma

Cutaneous squamous-cell carcinomas and keratoacanthomas are common findings in patients treated with BRAF inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research